Introduction If you read our site you may have noticed that we like Galectin Therapeutics (NASDAQ: GALT). Galectin Therapeutics is a biotechnology company advancing GR-MD-02, their lead drug … [Read more...] about GALT Update – Rights Offering
Introduction Recro Pharma (NASDAQ: REPH) engages in the research and development of non-opioid therapeutics for the treatment of acute postoperative pain. REPH is currently developing three … [Read more...] about $REPH – Recro Pharma, PDUFA Swing Trade
Leave a comment and click here to sub for MS Equity Analysis and Swing Moves. Introduction You may have recently seen hype about Corbus Pharmaceuticals (Nasdaq: CRBP), … [Read more...] about CRBP – Is Corbus Pharmaceuticals a good buy?